Skip to main content

Pharmacy Retail Market in India 2022: Advanced Medical Infrastructure and the Launch of New Patented Drugs Drive Growth - ResearchAndMarkets.com

The "Pharmacy Retail Market in India 2022" report has been added to ResearchAndMarkets.com's offering.

The pharmacy retail market has increased rapidly in the past few years, owing to the growing population and patient pool, and affordability of medicines. Consumers have improved access to medicines because of advanced medical infrastructure, launch of patented drugs. But factors such as low-profit margins, price control measures, and poor inventory management hinder market growth.

Market insights:

In 2020, the pharmacy retail market was valued at INR 1,783.83 Bn and is expected to reach INR 3,078.46 Bn by 2026, expanding at a CAGR of 12.02%. The organized retail pharmacy sector stood at INR 134.21 Bn in the same year and is anticipated to reach INR 370.39 Bn by 2026. The unorganized sector was valued at INR 1548.55 Bn in 2020 and is likely to reach INR 2390.20 Bn by 2026. The revenue of online retail sector stood at INR 38.15 Bn in 2020 and is likely to reach 317.87 Bn in 2026. The online retail channels sector is the fastest growing, owing to the rise in the number of internet users and increase in technological advancements. It was valued at 38.15 Bn in 2020 and is projected to reach 317.87 Bn in 2026, expanding at a CAGR of 44.44%.

Segment insights:

The pharmacy retail market is segmented into organized, unorganized, and online retail based on channels. The unorganized segment comprises local medical shop owners and it held an 88.70% market share in 2021. The organized sector consists of large players licensed to sell drugs and registered for sales and income tax. It had a share of 8.50% in 2021. Online pharmacy retail is an emerging segment with a 2.80% market share.

Owing to increase in internet users and technological advancements the online pharmacy retail channels are expected to expand at a CAGR of 44.34% during the 2022 - 2026 period. The pharmacy retail market is also segmented into generic, OTC, and patented drugs based on drug types. Generic drugs have identical chemical composition, dosage effects, side effects, and administration routes such as that of patented original ones.

Last year, generic drugs held a market share of 71%. OTC drugs can be sold to customers without a prescription through a medical practitioner. The segment had an 18.18% market share in 2021. The patented drugs were introduced by global drug manufacturers, used in various therapeutic areas such as oncology, anti-infective and cardiac treatment. Last year, patented drugs held a share of 10.82%.

Key Topics Covered:

Chapter 1: Executive summary

Chapter 2: Socio-economic indicators

Chapter 3: Introduction

3.1. Market definition and structure

Chapter 4: Market overview

4.1. Pharmacy retail market in India - An overview

4.1.1. Market size and growth forecast (2020 - 2026e)

Chapter 5: Market segmentation

5.1. Pharmacy retail market in India - Segmentation

5.1.1. Share based on retail channels (%) (2020 and 2026e)

5.1.1.1. Revenue for the organized sector (2020 - 2026e)

5.1.1.2. Revenue for the unorganized sector (2020 - 2026e)

5.1.1.3. Revenue for online retail (2020 - 2026e)

5.1.2. Share based on drug type (%) (2020 and 2026e)

5.1.2.1. Revenue for generic drugs (2020 - 2026e)

5.1.2.2. Revenue for OTC drugs (2020 - 2026e)

5.1.2.3. Revenue for patented drugs (2020 - 2026e)

Chapter 6: Impact of COVID-19

6.1. Impact of COVID-19

Chapter 7: Market Influencers

7.1. Market drivers

7.2. Market challenges

Chapter 8: Mergers and acquisitions

8.1. Mergers and acquisitions

Chapter 9: Competitive landscape

Chapter 10: Recent developments

10.1. Recent developments

Chapter 11: Appendix

11.1. Research methodology

11.2. About the Publisher

11.3. Disclaimer

Companies Mentioned

  • Apollo Pharmacies Limited
  • Emami Frank Ross Limited
  • Medlife
  • MedPlus Health Services Private Limited
  • Netmeds Marketplace Limited
  • Noble Medichem Pvt. Ltd. (Noble Plus)
  • RWL Healthworld Limited (Fortis Healthworld)
  • Wellness Forever Pharmacy
  • 1mg
  • 91Streets Media Technologies Private Limited (PharmEasy)

For more information about this report visit https://www.researchandmarkets.com/r/alk06b

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.